GUIDANCE and SUPPLEMENT Diversity in Clinical Trials
The University of Washington must comply with a new Washington State law (RCW 69.78) which aims to improve participation in clinical trials from underrepresented communities.
HSD has drafted guidance and a supplement outlining the UW policies and procedures for complying with the State law. These materials are posted here so that the UW research community may review and provide feedback on them from now until September 16th. Feedback may be embedded as comments and/or tracked changes within the Word document or in whatever method you prefer. Please send all feedback to hsdinfo@uw.edu.
A virtual town hall was held on September 4, 2024 where HSD provided a 30 minute overview presentation of the guidance and supplement, followed by a 60 minute Q&A session. A recording of the event is now available along with a complete list of questions and answers from the meeting.
Another virtual town hall will be held on September 20th, 2024. This town hall will include a 30 minute overview presentation about translation/interpreter services and community engagement resources followed by a 60 minute Q&A session. Registration is open and questions may be submitted in advance using the Contact Us form on the UW DCTI website. A post-session recording will be available.